The global market for Analgesics was valued at US$53.5 Billion in 2024 and is projected to reach US$72.8 Billion by 2030, growing at a CAGR of 5.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The use of analgesics has evolved significantly over the years, driven by advances in medical research and an increasing understanding of pain mechanisms. New formulations and delivery methods, such as extended-release tablets and transdermal patches, have improved the efficacy and convenience of pain management. Additionally, the development of combination drugs that incorporate multiple analgesics into a single dose has enhanced pain relief outcomes by targeting different pain pathways simultaneously. However, the widespread use of analgesics, particularly opioids, has led to significant public health challenges, including the opioid crisis, characterized by high rates of addiction and overdose. This has prompted a shift towards finding safer, non-addictive pain relief options, such as the development of new NSAIDs with fewer gastrointestinal side effects and increased research into non-pharmacological therapies.
The growth in the analgesics market is driven by several factors. Advancements in drug delivery systems have made analgesics more effective and user-friendly, with innovations like patient-controlled analgesia pumps and wearable drug delivery devices gaining popularity. The rising prevalence of chronic diseases such as arthritis and cancer, which often require long-term pain management, has also fueled demand for analgesics. Additionally, an aging global population is contributing to increased consumption of these medications, as older adults are more likely to experience chronic pain conditions. Consumer behavior trends show a growing preference for over-the-counter analgesics for quick and accessible pain relief, further boosting market growth. Moreover, increased healthcare spending and greater access to medical care in developing regions are expanding the market's reach. Pharmaceutical companies are also investing heavily in research and development to create new analgesics with better safety profiles and effectiveness, responding to the growing demand for safer alternatives to traditional painkillers. These factors collectively underscore the dynamic and expanding nature of the analgesics market.
Global Analgesics Market - Key Trends & Drivers Summarized
Analgesics, commonly known as painkillers, are a diverse group of drugs used to relieve pain. They work by blocking pain signals in the brain or by interfering with the brain's interpretation of these signals. There are several types of analgesics, each suited to different types and severities of pain. The most well-known categories include nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin, which reduce inflammation and are effective for mild to moderate pain. Opioids like morphine and oxycodone are stronger analgesics, often prescribed for severe pain but come with a risk of dependency and addiction. Another category is acetaminophen (paracetamol), which is widely used for mild to moderate pain relief and fever reduction, often included in over-the-counter medications.The use of analgesics has evolved significantly over the years, driven by advances in medical research and an increasing understanding of pain mechanisms. New formulations and delivery methods, such as extended-release tablets and transdermal patches, have improved the efficacy and convenience of pain management. Additionally, the development of combination drugs that incorporate multiple analgesics into a single dose has enhanced pain relief outcomes by targeting different pain pathways simultaneously. However, the widespread use of analgesics, particularly opioids, has led to significant public health challenges, including the opioid crisis, characterized by high rates of addiction and overdose. This has prompted a shift towards finding safer, non-addictive pain relief options, such as the development of new NSAIDs with fewer gastrointestinal side effects and increased research into non-pharmacological therapies.
The growth in the analgesics market is driven by several factors. Advancements in drug delivery systems have made analgesics more effective and user-friendly, with innovations like patient-controlled analgesia pumps and wearable drug delivery devices gaining popularity. The rising prevalence of chronic diseases such as arthritis and cancer, which often require long-term pain management, has also fueled demand for analgesics. Additionally, an aging global population is contributing to increased consumption of these medications, as older adults are more likely to experience chronic pain conditions. Consumer behavior trends show a growing preference for over-the-counter analgesics for quick and accessible pain relief, further boosting market growth. Moreover, increased healthcare spending and greater access to medical care in developing regions are expanding the market's reach. Pharmaceutical companies are also investing heavily in research and development to create new analgesics with better safety profiles and effectiveness, responding to the growing demand for safer alternatives to traditional painkillers. These factors collectively underscore the dynamic and expanding nature of the analgesics market.
Scope of the Study
The report analyzes the Analgesics market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments:
Drug Type (Prescription, OTC); Drug Class (Opioids, NSAIDs, Other Drug Classes); Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal).Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Prescription Analgesics segment, which is expected to reach US$43.8 Billion by 2030 with a CAGR of a 5.0%. The OTC Analgesics segment is also set to grow at 5.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $17.2 Billion in 2024, and China, forecasted to grow at an impressive 7.1% CAGR to reach $10.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Bristol-Myers Squibb Company, Bayer AG, Biological E. Ltd., Anabolic Laboratories LLC, BioDelivery Sciences International, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Analgesics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Analgesics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Analgesics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 146 major companies featured in this Analgesics market report include:
- Bristol-Myers Squibb Company
- Bayer AG
- Biological E. Ltd.
- Anabolic Laboratories LLC
- BioDelivery Sciences International, Inc.
- Brawn Laboratories Ltd.
- Angelini Holding S.p.A.
- AFT Pharmaceuticals Limited
- APT Asia Pacific
- Church & Dwight (Australia) Pty Ltd.
- Alliance Design and Development Group, Inc.
- Active Releaf Wellness Inc.
- Abiogen Pharma S.p.A.
- B-New Limited
- Celgene Corporation
Table of Contents
I. METHODOLOGYMII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bristol-Myers Squibb Company
- Bayer AG
- Biological E. Ltd.
- Anabolic Laboratories LLC
- BioDelivery Sciences International, Inc.
- Brawn Laboratories Ltd.
- Angelini Holding S.p.A.
- AFT Pharmaceuticals Limited
- APT Asia Pacific
- Church & Dwight (Australia) Pty Ltd.
- Alliance Design and Development Group, Inc.
- Active Releaf Wellness Inc.
- Abiogen Pharma S.p.A.
- B-New Limited
- Celgene Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 578 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 53.5 Billion |
| Forecasted Market Value ( USD | $ 72.8 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
